Cutler Group LP Sarepta Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$93.7 - $141.53 $1.48 Million - $2.24 Million	-15,800 Reduced 37.0%	26,900 $603,000
Q4 2023 Jan 18, 2024	BUY	$67.31 - $124.76 $33,655 - $62,380	500 Added 1.18%	42,700 $301,000
Q3 2023 Nov 07, 2023	BUY	$102.5 - $123.59 $3.56 Million - $4.29 Million	34,700 Added 462.67%	42,200 $642,000
Q2 2023 Jul 18, 2023	SELL	$106.4 - $157.19 $883,120 - $1.3 Million	-8,300 Reduced 52.53%	7,500 $208,000
Q1 2023 May 01, 2023	SELL	$117.53 - $155.99 $810,957 - $1.08 Million	-6,900 Reduced 30.4%	15,800 $432,000
Q4 2022 Feb 07, 2023	SELL	$100.86 - $132.13 $1.87 Million - $2.44 Million	-18,500 Reduced 44.9%	22,700 $722,000
Q3 2022 Oct 25, 2022	BUY	$75.71 - $119.24 $355,836 - $560,428	4,700 Added 12.88%	41,200 $580,000
Q2 2022 Aug 04, 2022	SELL	$62.69 - $88.44 $789,894 - $1.11 Million	-12,600 Reduced 25.66%	36,500 $116,000
Q1 2022 Apr 14, 2022	SELL	$63.15 - $90.42 $1.59 Million - $2.27 Million	-25,100 Reduced 33.83%	49,100 $234,000
Q4 2021 Jan 18, 2022	BUY	$77.28 - $99.42 $5.34 Million - $6.87 Million	69,100 Added 1354.9%	74,200 $509,000
Q3 2021 Oct 26, 2021	SELL	$65.97 - $92.48 $409,014 - $573,376	-6,200 Reduced 54.87%	5,100 $15,000
Q2 2021 Jul 19, 2021	BUY	$69.38 - $86.75 $492,597 - $615,925	7,100 Added 169.05%	11,300 $20,000
Q1 2021 Apr 26, 2021	SELL	$72.25 - $168.95 $1.27 Million - $2.97 Million	-17,600 Reduced 80.73%	4,200 $15,000
Q4 2020 Jan 21, 2021	BUY	$125.56 - $178.74 $966,812 - $1.38 Million	7,700 Added 54.61%	21,800 $582,000
Q3 2020 Oct 27, 2020	BUY	$127.12 - $172.34 $114,408 - $155,106	900 Added 6.82%	14,100 $232,000
Q2 2020 Jul 22, 2020	BUY	$93.0 - $171.7 $83,700 - $154,530	900 Added 7.32%	13,200 $526,000
Q1 2020 May 07, 2020	BUY	$82.38 - $131.64 $8,238 - $13,163	100 Added 0.82%	12,300 $151,000
Q4 2019 Feb 06, 2020	SELL	$76.53 - $135.58 $1.59 Million - $2.82 Million	-20,800 Reduced 63.03%	12,200 $118,000
Q3 2019 Oct 28, 2019	SELL	$72.81 - $156.91 $72,810 - $156,910	-1,000 Reduced 2.94%	33,000 $37,000
Q2 2019 Aug 09, 2019	BUY	$112.21 - $151.95 $2.06 Million - $2.8 Million	18,400 Added 117.95%	34,000 $656,000
Q1 2019 May 10, 2019	SELL	$106.67 - $151.68 $1.09 Million - $1.55 Million	-10,200 Reduced 39.53%	15,600 $135,000
Q4 2018 Feb 05, 2019	SELL	$97.32 - $148.76 $379,548 - $580,164	-3,900 Reduced 13.13%	25,800 $388,000
Q3 2018 Nov 07, 2018	SELL	$115.31 - $161.51 $265,213 - $371,473	-2,300 Reduced 7.19%	29,700 $1.74 Million
Q2 2018 Aug 10, 2018	BUY	$71.74 - $153.69 $882,401 - $1.89 Million	12,300 Added 62.44%	32,000 $1.37 Million
Q1 2018 May 11, 2018	SELL	$54.02 - $82.27 $1.46 Million - $2.23 Million	-27,100 Reduced 57.91%	19,700 $192,000
Q4 2017 Jan 17, 2018	SELL	$47.64 - $56.75 $1.86 Million - $2.22 Million	-39,100 Reduced 45.52%	46,800 $742,000
Q3 2017 Oct 17, 2017	BUY	$35.73 - $47.15 $3.07 Million - $4.05 Million	85,900	85,900 $858,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.25 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.09 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$759 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$528 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$518 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.6B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account